HPV self-collection

1 paper2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: Pfizer and 1 more

Human trial1

Outcomes

Follow-up compliance

no changein humans1

1 study

HPV self-collection has no effect on follow-up compliance in humans.
“Follow-up compliance was 89.6% and 71% at triage/treatment and 6-month visits, respectively, without significant differences between study arms.”
Human trialcervical cancer screeningfemales
Participation and Follow-Up Compliance in Cervical Cancer Screening According to Delivery Strategy for HPV Self-Collection: A Community Trial in Underserved Colombian Areas
Cancer medicine1 Aug 2026

Screening participation

upin humans1

1 study

HPV self-collection increases screening participation in humans (49% vs 26%).
“Participation rates were 49% (95% CI: 46-53) in the self-collected and 26% (95% CI: 22.8-29.5) in the clinician-collected arm.”
Human trialcervical cancer screeningfemales
Participation and Follow-Up Compliance in Cervical Cancer Screening According to Delivery Strategy for HPV Self-Collection: A Community Trial in Underserved Colombian Areas
Cancer medicine1 Aug 2026